LPTX - Leap Therapeutics EPS in-line misses on revenue
Leap Therapeutics (LPTX): Q4 GAAP EPS of -$0.09 in-line.Revenue of $0.38M misses by $0.01M.Press Release
For further details see:
Leap Therapeutics EPS in-line, misses on revenueLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get LPTX Alerts
News, Short Squeeze, Breakout and More Instantly...